A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...
EDMONTON, AB, April 20, 2026 /CNW/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX® platform, today announced the publication of a peer-reviewed stud ...
Following the PRECISION trial, prostate multiparametric MRI has been adopted as the first-line investigation for suspected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results